Customer Success

As specialists in droplet microfluidic screening, we evaluated multiple technologies and identified the ModaFlow platform as the most efficient in terms of sample economy, usability, and reproducibility. The instrument is highly intuitive to operate, and it consistently delivers reliable, high‑quality results. To date, we have successfully applied the system for hydrogel droplet generation within the context of compound library screening. Furthermore, the customer service and application support teams have been very responsive, knowledgeable, and quick to address all our questions. Overall, we are extremely satisfied with the platform and the support provided.

Evelien Mathieu

PhD, Senior Scientist Lead Characterization

Sanofi

We have been using the OneFlow system for spheroid formation with ADMSCs (namely), and it has proven to be a very reliable and user-friendly platform. The installation was straightforward, and the instrument was easy to integrate into our workflow. We particularly appreciate the robustness and reproducibility of the process. The system is easy to operate and allows us to generate consistent spheroids at very high throughput.

Darius Widera, Megan Childs and Ce Zhang

Professor, PhD Student and PhD Student

University of Reading - UK

We have been using the OneFlow™ system to generate primary human hepatocyte spheroids for drug testing. Thanks to the droplet-based approach, we have found that spheroids form faster and more homogeneously than with traditional methods. We particularly appreciate the OneFlow’s ease of use, robustness and reproducibility. Droplet generation is highly efficient, with minimal sample loss or dead volume, which is particularly valuable when working with precious primary cells. The LiveDrop team has also provided excellent support, with responsive technical assistance and regular follow-up. Overall, our experience with OneFlow™ has been very positive.

Brinton Seashore-Ludlow and Karolina Juhani

Group leader and PhD Student

Karolinska Institute

Droplet microfluidics integrated with LiveDrop’s advanced bioassays is revolutionizing immunology research. These tools enable high-throughput B-cell screening (sequencing?), monoclonal antibody discovery, and single-cell antibody response studies with unmatched precision. A game-changer technology to support innovation in Life Sciences. By rapidly screening plasma cells and Fc receptor interactions, LiveDrop drive breakthroughs in autoimmune and allergy therapies, transforming our understanding of human immunity.

Adrien Boes

PhD

CER Group, Belgium

Thank you again for the LiveDrop demo last week. We greatly appreciated the overall experience! Fast priming protocol and robustness of the priming method - Easy recovery of the generated emulsion - Low dead volume - Real-time visual monitoring of the droplet generation process I greatly appreciated the expertise of both colleagues, as well as their dedication to adapt to our needs and planned experiments. Explanations were always clear and detailed.

Heshuang Qu

PhD Post doc researcher

Karolinska Institute - Sweden

At Cellistic, we are committed to advance allogeneic cell therapy using iPSC. Our iPSC allogeneic cell therapy platforms Pulse and Echo are build using state of the art technology. To advance our capabilities further we are thrilled to work with LiveDrop’s advanced microfluidic technology. This technology has several benefits and perfectly aligns with our mission to make cell therapies more accessible and affordable. By enhancing cell line development precision and accelerating manufacturing processes, we are reinforcing our commitment to delivering cutting-edge cell therapy solutions with greater efficiency.

Stefan Braam

Founder and CTO

Cellistic